Update on Sjögren's Syndrome 2018
- PMID: 32185326
- PMCID: PMC7045943
- DOI: 10.31138/mjr.29.4.193
Update on Sjögren's Syndrome 2018
Abstract
Primary Sjögren's syndrome (pSS) is a chronic systemic autoimmune disease with a diverse clinical picture, extending from exocrine involvement to extraglandular manifestations. Although pSS remains a disease of unknown etiology, an interaction between genetic susceptibility and environmental triggers is thought to play a key role in disease initiation and progress. Despite the extensive research during the past years, the pathogenetic mechanisms are still elusive and effective therapeutic intervention is still missing. This review aims to provide an overview of the recent literature on the pathogenesis, clinical features and new therapeutic aspects of pSS.
Keywords: Sjögren’s syndrome; germinal centers; pathogenesis; salivary gland ultrasonography; treatment.
© 2018 The Mediterranean Journal of Rheumatology (MJR).
References
-
- Nilsson AM, Tufvesson E, Hesselstrand R, Olsson P, Wollmer P, Mandl T . Increased B-cell activating factor, interleukin-6, and interleukin-8 in induced sputum from primary Sjögren’s syndrome patients . Scand J Rheumatol 2018. September 30 : 1 – 8 . [Epub ahead of print]. [ 10.1080/03009742.2018.1473488 ] [PMID: ] - DOI - PubMed
-
- Argyropoulou OD, Valentini E, Ferro F, Leone MC, Cafaro G, Bartoloni E, Baldini C . One year in review 2018; Sjögren’s syndrome. Clin Exp Rheumatol 2018. ; 36 ( Suppl. 112 ): 14 – 26 . - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous